Cardiac involvements in scleroderma Algerian patients
نویسندگان
چکیده
منابع مشابه
Diagnostic Value of NT-pro BNP Biomarker and Echocardiography in Cardiac Involvements in Beta-thalassemia Patients
Background N-terminal pro–B-type natriuretic peptide (NT-proBNP) is a marker to evaluate the cardiac involvement in thalassemia. We aimed to evaluate conventional and tissue Doppler echocardiography findings and its relation to plasma NT-pro BNP, Ferritin and Iron levels in beta-thalassemia patients. Materials and Methods This study performed on 164 participants equal of major beta- thalassemi...
متن کاملcardiac damage in left breast cancer patients
Introduction :Today there is general awareness of the potential damage to the heart in left- sided (more than in rightsided) breast cancer radiotherapy. Material & Method: Historical changes in tumor and heart doses are presented here along with the impact of different RT techniques and volumes. Results: Individual and pharm...
متن کاملRisk of cancer in patients with scleroderma.
he first report linking cancer with scleroderma (Scl) was 50 years ago when a case of alveolar cell carci-noma was described. 1 Since then there have been several further case reports and series linking Scl with cancer at various sites. 2 The sites of cancer most frequently reported are the lung 3 4 and breast 5 (perhaps reflecting their prevalence in the general population), but cancers at oth...
متن کاملCeliac disease screening in patients with scleroderma.
Both celiac disease and scleroderma have autoimmune etiology and affect the bowel causing diarrhea. As an association of autoimmune disease in a single individual is not rare, it is important to know if a patient with scleroderma may also have celiac disease. To analyze this we studied 105 scleroderma patients and 97 volunteers for IgA-EmA by indirect immunofluorescence assay. We could not find...
متن کاملImmune Stimulation in Scleroderma Patients Treated with
Scleroderma (SSc) is a fibrosing connective tissue disease that is poorly responsive to any treatment, including immune suppression. SSc shares many characteristics with chronic graft-versus-host disease (GVHD). Because the immunomodulatory drug thalidomide has proven beneficial in chronic GVHD, we studied the immune response and clinical effects of thalidomide in SSc patients. We treated 11 SS...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Cardiovascular Diseases Supplements
سال: 2017
ISSN: 1878-6480
DOI: 10.1016/s1878-6480(17)30154-4